Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience.

Xie, Lu; Xu, Jie; Guo, Wei; Wang, Zhen; Yao, Yang; Li, Jianmin; Lin, Jianhua; Xiao, Jianru; Yu, Xiuchun; Zhang, Weibin; Cai, Zhendong; Hua, Yingqi; Chen, Jing; Shao, Zengwu; Wu, Di; Wu, Sujia; Tu, Zhongqi; Zhang, Xiaojing

Xie, Lu; Xu, Jie; Guo, Wei; Wang, Zhen; Yao, Yang; Li, Jianmin; Lin, Jianhua; Xiao, Jianru; Yu, Xiuchun; Zhang, Weibin; Cai, Zhendong; Hua, Yingqi; Chen, Jing; Shao, Zengwu; Wu, Di; Wu, Sujia; Tu, Zhongqi; Zhang, Xiaojing.

Afiliación

Xie L; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Xu J; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Guo W; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Wang Z; Orthopedic Oncology, Xijing Hospital Air Force Medical University of PLA (The Fourth Military Medical University), Xi'an, China.
Yao Y; Medical Oncology, Shanghai Sixth People's Hospital, Shanghai, China.
Li J; Orthopedic Oncology, Qilu Hospital of Shandong University, Jinan, China.
Lin J; Musculoskeletal Tumor Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Xiao J; Orthopedic Oncology, Shanghai Changzheng Hospital, Shanghai, China.
Yu X; Orthopedic Oncology, Jinan Military General Hospital, Jinan, China.
Zhang W; Orthopedic Oncology, Ruijin Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China.
Cai Z; Orthopedic Oncology, Shanghai General Hospital, Shanghai, China.
Hua Y; Orthopedic Oncology, Shanghai General Hospital, Shanghai, China.
Chen J; Orthopedic Oncology and Medical Oncology, Wuhan Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Shao Z; Orthopedic Oncology and Medical Oncology, Wuhan Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Wu D; Medical Oncology, The First Affiliated Hospital of Jilin University, Changchun, China.
Wu S; Orthopedic Oncology, General Hospital of Eastern Theater Command, Nanjing, China.
Tu Z; Orthopedic Oncology, Huaxi Hospital West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), Chengdu, China.
Zhang X; Musculoskeletal Tumor Center, Liaoning Cancer Hospital & Institute, Shenyang, China.

Front Oncol ; 11: 696865, 2021.

Article en En | MEDLINE | ID: mdl-34367981

Palabras clave

apatinib; osteosarcoma; prophylaxis; toxicity; treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Systematic_reviews Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google